{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:41:35Z","timestamp":1790487695416,"version":"4.1.0"},"reference-count":55,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>The BRAF V600E mutation (BRAF-MUT) confers an aggressive phenotype in papillary thyroid carcinoma, but unidentified additional genomic abnormalities may be required for full phenotypic expression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>RNA sequencing (RNA-Seq) was performed to identify genes differentially expressed between BRAF-MUT and BRAF wild-type (BRAF-WT) tumors and to correlate changes to patient clinical status.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design:<\/jats:title>\n                  <jats:p>BRAF-MUT and BRAF-WT tumors were identified in patients with T1N0 and T2\u20133N1 tumors evaluated in a referral medical center. Gene expression levels were determined (RNA-Seq) and fusion transcripts were detected. Multiplexed capture\/detection and digital counting of mRNA transcripts (nCounter, NanoString Technologies) validated RNA-Seq data for immune system-related genes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients:<\/jats:title>\n                  <jats:p>BRAF-MUT patients included nine women, three men; nine were TNM stage I and three were stage III. Three (25%) had tumor infiltrating lymphocytes. BRAF-WT included five women, three men; all were stage I, and five (62.5%) had tumor infiltrating lymphocytes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>RNA-Seq identified 560 of 13 085 genes differentially expressed between BRAF-MUT and BRAF-WT tumors. Approximately 10% of these genes were related to MetaCore immune function pathways; 51 were underexpressed in BRAF-MUT tumors, whereas 4 (HLAG, CXCL14, TIMP1, IL1RAP) were overexpressed. The four most differentially overexpressed immune genes in BRAF-WT tumors (IL1B; CCL19; CCL21; CXCR4) correlated with lymphocyte infiltration. nCounter confirmed the RNA-Seq expression level data. Eleven different high-confidence fusion transcripts were detected (four interchromosomal; seven intrachromosomal) in 13 of 20 tumors. All in-frame fusions were validated by RT-PCR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>BRAF-MUT papillary thyroid cancers have reduced expression of immune\/inflammatory response genes compared with BRAF-WT tumors and correlate with lymphocyte infiltration. In contrast, HLA-G and CXCL14 are overexpressed in BRAF-MUT tumors. Sixty-five percent of tumors had between one and three fusion transcripts. Functional studies will be required to determine the potential role of these newly identified genomic abnormalities in contributing to the aggressiveness of BRAF-MUT and BRAF-WT tumors.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2013-2792","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T02:51:38Z","timestamp":1386039098000},"page":"E338-E347","source":"Crossref","is-referenced-by-count":60,"title":["RNA Sequencing Identifies Multiple Fusion Transcripts, Differentially Expressed Genes, and Reduced Expression of Immune Function Genes in BRAF (V600E) Mutant vs BRAF Wild-Type Papillary Thyroid Carcinoma"],"prefix":"10.1210","volume":"99","author":[{"given":"Robert C.","family":"Smallridge","sequence":"first","affiliation":[{"name":"Department of Medicine (R.C.S.), Division of Endocrinology and Metabolism, Mayo Clinic, Jacksonville, Florida 32224"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Chindris","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology\u2013Head and Neck Surgery (A.M.C., J.D.C.), Mayo Clinic, Jacksonville, Florida 32224"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan W.","family":"Asmann","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research (Y.W.A., D.J.S.), Mayo Clinic, Jacksonville, Florida 32224"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Casler","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology\u2013Head and Neck Surgery (A.M.C., J.D.C.), Mayo Clinic, Jacksonville, Florida 32224"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Serie","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research (Y.W.A., D.J.S.), Mayo Clinic, Jacksonville, Florida 32224"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honey V.","family":"Reddi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology (H.V.R., N.L.E., B.M.), Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall W.","family":"Cradic","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology (K.W.C., S.K.G.), Division of Clinical Biochemistry and Immunology, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rivera","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology (M.R.), Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Grebe","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology (K.W.C., S.K.G.), Division of Clinical Biochemistry and Immunology, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Necela","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology (B.N., J.M.C., J.A.C., E.A.T.), Mayo Clinic, Jacksonville, Florida 32224"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman L.","family":"Eberhardt","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology (H.V.R., N.L.E., B.M.), Mayo Clinic, Rochester, Minnesota 55905"},{"name":"Department of Biochemistry and Molecular Biology (N.L.E.), Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Carr","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology (B.N., J.M.C., J.A.C., E.A.T.), Mayo Clinic, Jacksonville, Florida 32224"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"McIver","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology (H.V.R., N.L.E., B.M.), Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Copland","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology (B.N., J.M.C., J.A.C., E.A.T.), Mayo Clinic, Jacksonville, Florida 32224"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Aubrey","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology (B.N., J.M.C., J.A.C., E.A.T.), Mayo Clinic, Jacksonville, Florida 32224"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614210609100_B1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"2020071614210609100_B2","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1210\/jc.2010-0337","article-title":"Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases","volume":"95","author":"Basolo","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614210609100_B3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.surg.2010.09.005","article-title":"BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer","volume":"148","author":"O'Neill","year":"2010","journal-title":"Surgery"},{"key":"2020071614210609100_B4","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1038\/sj.onc.1208822","article-title":"Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET\/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis","volume":"24","author":"Giordano","year":"2005","journal-title":"Oncogene"},{"key":"2020071614210609100_B5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1677\/ERC-09-0288","article-title":"Molecular signatures of thyroid follicular neoplasia","volume":"17","author":"Borup","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"2020071614210609100_B6","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1038\/sj.onc.1207980","article-title":"Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer","volume":"23","author":"Frattini","year":"2004","journal-title":"Oncogene"},{"key":"2020071614210609100_B7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/modpathol.2010.112","article-title":"Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns","volume":"23","author":"Rivera","year":"2010","journal-title":"Mod Pathol"},{"key":"2020071614210609100_B8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2010.01.007","article-title":"Molecular prognostic markers in papillary and follicular thyroid cancer: current status and future directions","volume":"322","author":"Handkiewicz-Junak","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"2020071614210609100_B9","doi-asserted-by":"crossref","first-page":"e17490","DOI":"10.1371\/journal.pone.0017490","article-title":"Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing","volume":"6","author":"Sun","year":"2011","journal-title":"PLoS One"},{"key":"2020071614210609100_B10","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1210\/jc.2009-1349","article-title":"Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status","volume":"94","author":"Cradic","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614210609100_B11","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol"},{"key":"2020071614210609100_B12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","article-title":"TopHat: discovering splice junctions with RNA-Seq","volume":"25","author":"Trapnell","year":"2009","journal-title":"Bioinformatics"},{"key":"2020071614210609100_B13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2020071614210609100_B14","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1093\/nar\/gkr362","article-title":"A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines","volume":"39","author":"Asmann","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2020071614210609100_B15","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1158\/0008-5472.CAN-11-3142","article-title":"Detection of redundant fusion transcripts as biomarkers or disease-specific therapeutic targets in breast cancer","volume":"72","author":"Asmann","year":"2012","journal-title":"Cancer Res"},{"key":"2020071614210609100_B16","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","article-title":"Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas","volume":"68","author":"Jones","year":"2008","journal-title":"Cancer Res"},{"key":"2020071614210609100_B17","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0503039102","article-title":"Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene","volume":"102","author":"Borrello","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614210609100_B18","doi-asserted-by":"crossref","first-page":"15044","DOI":"10.1073\/pnas.251547398","article-title":"Gene expression in papillary thyroid carcinoma reveals highly consistent profiles","volume":"98","author":"Huang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614210609100_B19","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1158\/0008-5472.CAN-04-3078","article-title":"Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications","volume":"65","author":"Jarzab","year":"2005","journal-title":"Cancer Res"},{"key":"2020071614210609100_B20","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2006.06.7330","article-title":"Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers","volume":"24","author":"Griffith","year":"2006","journal-title":"J Clin Oncol"},{"key":"2020071614210609100_B21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1755-8794-4-30","article-title":"Identification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation","volume":"4","author":"Vierlinger","year":"2011","journal-title":"BMC Med Genomics"},{"key":"2020071614210609100_B22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3904\/kjim.2010.25.4.399","article-title":"Microarray analysis of papillary thyroid cancers in Korean","volume":"25","author":"Kim","year":"2010","journal-title":"Korean J Intern Med"},{"key":"2020071614210609100_B23","first-page":"3413","article-title":"Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression","volume":"30","author":"Mo","year":"2010","journal-title":"Anticancer Res"},{"key":"2020071614210609100_B24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/modpathol.2011.140","article-title":"CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas","volume":"25","author":"Torregrossa","year":"2012","journal-title":"Mod Pathol"},{"key":"2020071614210609100_B25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.humimm.2012.12.012","article-title":"Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer","volume":"74","author":"Nunes","year":"2013","journal-title":"Hum Immunol"},{"key":"2020071614210609100_B26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.semcancer.2012.03.003","article-title":"The role of classical and non-classical HLA class I antigens in human tumors","volume":"22","author":"Bukur","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"2020071614210609100_B27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10408363.2012.677947","article-title":"The immunosuppressive molecule HLA-G and its clinical implications","volume":"49","author":"Gonz\u00e1lez","year":"2012","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2020071614210609100_B28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.humimm.2012.07.321","article-title":"Importance of HLA-G expression and tumor infiltrating lymphocytes in molecular subtypes of breast cancer","volume":"73","author":"Dong","year":"2012","journal-title":"Hum Immunol"},{"key":"2020071614210609100_B29","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1210\/jc.2012-2231","article-title":"Soluble human leukocyte antigen-g and its insertion\/deletion polymorphism in papillary thyroid carcinoma: novel potential biomarkers of disease?","volume":"97","author":"Dardano","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614210609100_B30","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-07-4372","article-title":"Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis","volume":"14","author":"Oler","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2020071614210609100_B31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/ERC-11-0076","article-title":"BRAFV600E mutation, TIMP-1 upregulation, and NF-\u03baB activation: closing the loop on the papillary thyroid cancer trilogy","volume":"18","author":"Bommarito","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"2020071614210609100_B32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2012-01-404699","article-title":"Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS","volume":"120","author":"Barreyro","year":"2012","journal-title":"Blood"},{"key":"2020071614210609100_B33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevOncog.v12.i3-4.40","article-title":"Recurrent fusion oncogenes in carcinomas","volume":"12","author":"Teixeira","year":"2006","journal-title":"Crit Rev Oncog"},{"key":"2020071614210609100_B34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/PAP.0b013e318273baae","article-title":"Morphologic features of carcinomas with recurrent gene fusions","volume":"19","author":"Qi","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"2020071614210609100_B35","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/gcc.22003","article-title":"Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes","volume":"51","author":"Celestino","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"2020071614210609100_B36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2012.10.087","article-title":"ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412","volume":"429","author":"Chi","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071614210609100_B37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semcancer.2005.01.003","article-title":"ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages","volume":"15","author":"Lannon","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"2020071614210609100_B38","doi-asserted-by":"crossref","first-page":"e51203","DOI":"10.1371\/journal.pone.0051203","article-title":"New fusion transcripts identified in normal karyotype acute myeloid leukemia","volume":"7","author":"Wen","year":"2012","journal-title":"PLoS One"},{"key":"2020071614210609100_B39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1101\/gr.133645.111","article-title":"A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing","volume":"22","author":"Ju","year":"2012","journal-title":"Genome Res"},{"key":"2020071614210609100_B40","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1158\/0008-5472.CAN-06-1396","article-title":"Tumor-suppressive effects of pannexin 1 in C6 glioma cells","volume":"67","author":"Lai","year":"2007","journal-title":"Cancer Res"},{"key":"2020071614210609100_B41","doi-asserted-by":"crossref","first-page":"29184","DOI":"10.1074\/jbc.M112.377176","article-title":"Loss of pannexin 1 attenuates melanoma progression by reversion to a melanocytic phenotype","volume":"287","author":"Penuela","year":"2012","journal-title":"J Biol Chem"},{"key":"2020071614210609100_B42","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1158\/1078-0432.CCR-11-0596","article-title":"The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myeloma","volume":"17","author":"Agnelli","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2020071614210609100_B43","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1242\/dev.02350","article-title":"Medaka simplet (FAM53B) belongs to a family of novel vertebrate genes controlling cell proliferation","volume":"133","author":"Thermes","year":"2006","journal-title":"Development"},{"key":"2020071614210609100_B44","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1038\/onc.2008.317","article-title":"The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells","volume":"27","author":"McKinnon","year":"2008","journal-title":"Oncogene"},{"key":"2020071614210609100_B45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.gene.2011.07.018","article-title":"RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells","volume":"486","author":"Mao","year":"2011","journal-title":"Gene"},{"key":"2020071614210609100_B46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13277-011-0265-3","article-title":"PEBP4 gene expression and its significance in invasion and metastasis of non-small cell lung cancer","volume":"33","author":"Yu","year":"2012","journal-title":"Tumour Biol"},{"key":"2020071614210609100_B47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11010-010-0490-x","article-title":"Differentiation linked regulation of telomerase activity by Makorin-1","volume":"342","author":"Salvatico","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"2020071614210609100_B48","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/jnci\/djs424","article-title":"Acceleration of gastric tumorigenesis through MKRN1-mediated posttranslational regulation of p14ARF","volume":"104","author":"Ko","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"2020071614210609100_B49","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1158\/1535-7163.MCT-09-0880","article-title":"Induction of clusterin by AKT\u2014role in cytoprotection against docetaxel in prostate tumor cells","volume":"9","author":"Zhong","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"2020071614210609100_B50","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1158\/0008-5472.CAN-12-0254","article-title":"Clusterin mediates TGF-\u03b2-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells","volume":"72","author":"Shiota","year":"2012","journal-title":"Cancer Res"},{"key":"2020071614210609100_B51","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03699.x","article-title":"The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies","volume":"72","author":"Muzza","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614210609100_B52","first-page":"286","article-title":"Inflammation in thyroid oncogenesis","volume":"2","author":"Liotti","year":"2012","journal-title":"Am J Cancer Res"},{"key":"2020071614210609100_B53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/thy.2012.0566","article-title":"Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers","volume":"23","author":"French","year":"2013","journal-title":"Thyroid"},{"key":"2020071614210609100_B54","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1210\/jc.2013-1309","article-title":"Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis","volume":"98","author":"Dvorkin","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614210609100_B55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/thy.2008.0144","article-title":"Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis","volume":"19","author":"Kim","year":"2009","journal-title":"Thyroid"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/2\/E338\/9049035\/jcemE338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/2\/E338\/9049035\/jcemE338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:02:40Z","timestamp":1594951360000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/2\/E338\/2537219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,1]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-2792","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,1]]}}}